Catalyst Calendar - February 18, 2026 (Morning)

 ## Major Catalysts Mentioned **FDA Chief Marty Makary's Statement** - Date: TBD - Why it matters: The FDA chief's assertion that "everything should be over-the-counter" unless a drug is unsafe or addictive could lead to significant regulatory changes. This may impact pharmaceutical companies and their product offerings. - Stocks affected: **$PFE**, **$JNJ**, **$MRK** **Oil Price Volatility Following U.S.-Iran Tensions** - Date: TBD - Why it matters: Oil prices surged over 2% after reports indicated that Iran ignored key U.S. demands, raising the stakes for potential military action. This could have lasting effects on oil supply and pricing. - Stocks affected: **$XOM**, **$CVX**, **$OXY** **Moderna's Seasonal Flu Vaccine Review** - Date: TBD - Why it matters: The FDA's agreement to review Moderna's seasonal flu vaccine could lead to new product approvals, impacting the company's future revenue streams and competitive position in the vaccine market. - Stocks affected: **$MRNA** **Tesla's Trading Momentum Concerns** - Date: TBD - Why it matters: Reports suggest that Tesla's trading momentum has been declining since December, raising concerns about the company's stock performance and potential future sales. - Stocks affected: **$TSLA** ## Earnings on Deck - **$MEIYF** - Reports: Q4 2025 Earnings Call - Key watch: Earnings performance relative to expectations. ## Highest Conviction Catalyst - What: FDA's review of Moderna's seasonal flu vaccine. - When: TBD - Why it matters: A successful review and subsequent approval could position Moderna as a leader in the seasonal flu vaccine market, potentially increasing revenue and market share significantly. - Trade idea: Consider buying into **$MRNA** as a speculative play on the stock ahead of potential positive news from the FDA.